Clinical Trial

IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 23, 2024 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
IMPLEMENT aims to develop, test and establish a sustainable access structure for quality-assured oncological exercise therapy (qOET) in Germany as a model within the funding period of three years. This will be done in three phases: Phase 1: In the first step, a characterization of the existing implementation structures and the existing barriers and needs as well as the establishment of the cooperation with the most important actors in the care system will take place. Phase 2: In the subsequent implementation process, concrete measures are practically implemented in subprojects for specific target groups (children/adolescents, adults) and specific regions (rural, urban) as well as the digital solutions and interface management. With the help of a mixed-methods design, the barriers and facilitating factors of the implementation of area-wide qSBT will be investigated during the project and fed into a "learning system" for adaptation and improvement. Phase 3: The success of the measures to increase patient participation in qOET and the development of the structures as well as the barrier and facilitating factors for an effective implementation will be addressed in a before-after comparison through evaluation steps and an economic accompanying evaluation will be carried out.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-03.
Trial Details
NCT Number NCT06496711
Lead Sponsor University of Cologne
Collaborators: Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, University of Regensburg, Ludwig-Maximilians - University of Munich, Technical University of Munich, Martin-Luther-Universität Halle-Wittenberg, University Hospital Schleswig-Holstein, Universitätsklinikum Hamburg-Eppendorf, University Hospital, Essen
Conditions Cancer
Enrollment 600 participants
Start Date 2023-09-01
Primary Completion 2025-11-30 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-08-23